Results 341 to 350 of about 656,371 (370)
Some of the next articles are maybe not open access.
Minimal Residual Disease in Prostate Cancer
2018Detection of minimal residual disease (MRD) in prostate cancer over several decades has greatly informed our understanding of dissemination and recurrence, but has not yet been routinely used in clinical care. Investigators have detected MRD by identification of prostate cancer cells in the bone marrow; termed disseminated tumor cells (DTCs) and blood;
Frank C. Cackowski, Russell S. Taichman
openaire +3 more sources
Minimal Residual Disease in Multiple Myeloma.
Presse medicaleN. Moukalled +3 more
semanticscholar +1 more source
Onconephrology: The intersections between the kidney and cancer
Ca-A Cancer Journal for Clinicians, 2021Mitchell H Rosner +2 more
exaly
Colorectal cancer statistics, 2020
Ca-A Cancer Journal for Clinicians, 2020Rebecca L Siegel +2 more
exaly
Targeting minimal residual disease [PDF]
Nature Reviews Drug Discovery, 2018 openaire +2 more sources
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Management of glioblastoma: State of the art and future directions
Ca-A Cancer Journal for Clinicians, 2020Aaron C Tan +2 more
exaly
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Ca-A Cancer Journal for Clinicians, 2019Marsela Braunstein +2 more
exaly